Crossmark

A proposal for validation of antibodies

Crossref DOI link: https://doi.org/10.1038/nmeth.3995

Published Online: 2016-09-05

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Uhlen, Mathias https://orcid.org/0000-0002-4858-8056
Bandrowski, Anita

Carr, Steven

Edwards, Aled

Ellenberg, Jan

Lundberg, Emma

Rimm, David L

Rodriguez, Henry

Hiltke, Tara

Snyder, Michael

Yamamoto, Tadashi
License Information

Text and Data Mining valid from 2016-09-05
More Information

Article History

First Online: 5 September 2016

Competing interests

: M.U. is cofounder of Atlas Antibodies, Affibody Medical, and Antibodypedia. S.C. is a consultant to Biogen and PTM BioLabs Inc. A.B. is the founder of SciCrunch Inc., the technology backing for the Resource Identification Initiative. E.L. acknowledges formal links to Atlas Antibodies. D.L.R. is a consultant to Amgen, Applied Cellular Diagnostics, AstraZeneca, Agendia, Bethyl Labs, Biocept, BMS, Cernostics, FivePrime, Genoptix/Novartis, Metamark Genetics, MDAgree, OptraScan, and Perkin Elmer; he has received honoraria from Genentech/Roche and Ventana; and he acknowledges research support from Cepheid, Genoptix, Gilead Sciences, Kolltan, Perkin Elmer, and Nantomics. D.L.R. holds equity in MDAgree.